Session Overview
Information coming soon!
Hear from Blake Gudgel, CEO, KluraLabs about his fight against the invisible enemy and efforts to safeguard us from the threats of viruses and bacteria. He will talk about his journey from licensing technology to real science and scalable solutions, how the landscape is changing and what regulatory bodies, the private and public sector can do to help drive change.
Blake will highlight how cutting-edge solutions can contribute to a healthier planet and safer society. Antimicrobial technologies, with their ability to kill bacteria and viruses, help prevent the spread of infectious diseases, protect vulnerable populations and the growing issue of global food waste. Similarly, sustainable material solutions have the potential to revolutionise our living and working environments by providing circular, safer, cleaner, and more hygienic spaces.
Meet Your Speaker
More information coming soon!
Blake isthe CEO of KluraLabs and has spent the last 16 years leading development and operations efforts in early-stage technology companies across the US and Europe.
Blake’s deep experience spans product development, finance, commercialization, corporate partnerships, scaling, and organizational culture. Holding degrees in Entrepreneurship/Venture Management and Marketing from the University of Oklahoma, Blake has dedicated his career to developing scalable technological solutions with positive social impact. His focus areas include health technology, military robotics, materials science and pharmaceuticals.
For two years, Blake served as the Director of the Office of Technology Development at his alma mater. There, he led tech transfer teams in commercializing the university’s IP portfolio through licensing agreements, spinouts, collaborative partnerships, and direct investments. Additionally, Blake has significant government advocacy experience. He has worked at the intersection of health policy and new technology, forging partnerships with multiple US federal departments, agencies, tech companies, and major health systems to launch technologies that improve health and economic outcomes.
Hosted by
Information coming soon!
Session Overview
Session information coming soon!
Hear from Blake Gudgel, CEO, KluraLabs about his fight against the invisible enemy and efforts to safeguard us from the threats of viruses and bacteria. He will talk about his journey from licensing technology to real science and scalable solutions, how the landscape is changing and what regulatory bodies, the private and public sector can do to help drive change.
Blake will highlight how cutting-edge solutions can contribute to a healthier planet and safer society. Antimicrobial technologies, with their ability to kill bacteria and viruses, help prevent the spread of infectious diseases, protect vulnerable populations and the growing issue of global food waste. Similarly, sustainable material solutions have the potential to revolutionise our living and working environments by providing circular, safer, cleaner, and more hygienic spaces.
Meet Your Panel / Speakers
Blake Gudgel
KluraLabs
Blake isthe CEO of KluraLabs and has spent the last 16 years leading development and operations efforts in early-stage technology companies across the US and Europe.
Blake’s deep experience spans product development, finance, commercialization, corporate partnerships, scaling, and organizational culture. Holding degrees in Entrepreneurship/Venture Management and Marketing from the University of Oklahoma, Blake has dedicated his career to developing scalable technological solutions with positive social impact. His focus areas include health technology, military robotics, materials science and pharmaceuticals.
For two years, Blake served as the Director of the Office of Technology Development at his alma mater. There, he led tech transfer teams in commercializing the university’s IP portfolio through licensing agreements, spinouts, collaborative partnerships, and direct investments. Additionally, Blake has significant government advocacy experience. He has worked at the intersection of health policy and new technology, forging partnerships with multiple US federal departments, agencies, tech companies, and major health systems to launch technologies that improve health and economic outcomes.
Hosted by
Information coming soon!
